← Leaderboards
Jiha Lee
University Of Michigan At Ann Arbor
$891,196
Attributed
$891,196
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $194.4K · FY2020–25$200K$150K$100K$50K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$891,196 · 2
By mechanism
K23$583,200 · 1
R03$307,996 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Richard A. Miller$53,224,142
- Denise Cortis Park$27,156,906
- Jersey Liang$7,357,656
- Kevin C Chung$13,606,879
- Neil Alexander$7,510,032
Others in their field
Other Emerging Leaders on “Inflammatory”
- Leigh A Johnson · University Of North Texas Hlth Sci Ctr$21,969,486
- Gary Fanger · Rise Therapeutics, Llc$20,823,569
- Gina Montealegre · Leidos Biomedical Research, Inc.$19,781,641
- Jeffrey Reich · Sparian Biosciences, Inc.$13,729,307
- Bjorn E Oskarsson · Mayo Clinic Jacksonville$11,846,278
- James Dale Berry · Brigham And Women'S Hospital$11,004,714
Research focus
InflammatoryInfectionEvaluationHuman Old Age (65+)IndexingDisease-Modifying Second-Line DrugsDisabilityElderlyFrequenciesGlucocorticoidsDoseAdverse EffectsAgingCareer DevelopmentCaringAffectChronicDrug UsageAcuteDiagnosisFutureCohortBiologicalMedicare Claim
Grant awards (5)
Understanding disease modifying antirheumatic drug use in older adults with late-onset rheumatoid arthritis$194,400
K23 · FY2025 · AG · contact PI
Understanding disease modifying antirheumatic drug use in older adults with late-onset rheumatoid arthritis$194,400
K23 · FY2024 · AG · contact PI
Understanding disease modifying antirheumatic drug use in older adults with late-onset rheumatoid arthritis$194,400
K23 · FY2023 · AG · contact PI
Evaluation of treatment patterns and prescription medication use among older adults with late-onset rheumatoid arthritis$153,928
R03 · FY2021 · AG · contact PI
Evaluation of treatment patterns and prescription medication use among older adults with late-onset rheumatoid arthritis$154,068
R03 · FY2020 · AG · contact PI